Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.
Milwaukee, WI
Joined May 2012
- Tweets15.7K
- Following6.4K
- Followers20.1K
- Likes8.2K
Pinned Tweet
Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: sitcancer.org/2026/home
Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: sitcancer.org/2026/home
Join experts in the IO field at Spring Scientific. Held Feb. 24–26 in San Diego, CA or virtual. This program will include in-depth discussions of cutting-edge technologies, and the newest clinical studies. Learn more and register here: sitcancer.org/edu/2027-sprin…
Connect with SITC members who share your scientific interests! Explore SITC’s three active Special Interest Groups (SIGs): ASPIRE, Peri-IO Safety and Microbiome. Discover opportunities to network, collaborate and advance cancer immunotherapy. Learn more: sitcancer.org/get-involved/s…
Use the Career Connections Online Job Board to find the right candidates for your open job positions. Through Nov. 30, save 20% on a single, 3- or 5- pack of job posts using code SITC26JOB or SITC26PACK. Learn more here: careerconnections.sitcancer.…
The SITC Sparkathon 2027 topic is “Next Generation of Cellular Therapies: In vivo, Ex vivo, Engagers and Beyond”. Apply by Nov. 12 and learn more about leadership development, collaborations & scientific exchange. sitcancer.org/sparkathon
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation" doi.org/10.1136/jitc-2026-01…
Society for Immunotherapy of Cancer retweeted
CRI STAR Sidi Chen, PhD (@sidichen) of @YaleMed joins @sitcancer for a webinar on systems immunology and T cell memory, key to durable immunotherapy responses. 🧬
🕛 Tue., Oct. 27 | 12–1:30 p.m. ET
Register: bit.ly/3U6Am1y
#CancerImmunotherapy #TCells
Hear directly from pharma leaders at High-Impact Talks from Pharma Leaders during #SITC26! Gain insights into oncology innovation, early research and development, and how emerging companies can align scientific promise with industry priorities. Join us! sitcancer.org/2026/schedule/…
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Sensory innervation shapes cancer immunotherapy efficacy and adverse events" doi.org/10.1136/jitc-2026-01…
Society for Immunotherapy of Cancer retweeted
New #JITC article: "CCNE1 overexpression drives a cGAS–STING-dependent interferon response and sensitizes HRD-positive ovarian cancer to immune checkpoint blockade" doi.org/10.1136/jitc-2026-01…
Congratulations! See you in Phoenix!
🎉 We are excited to announce that Bushangqing Liu, a PhD candidate at @DukeU, has been selected as Biointron’s Q4 2026 Travel Grant recipient!
📍 Liu will be attending @sitcancer (SITC 2026) from Nov 4-8. Biointron will be at booth #712!
biointron.com/promotions/tra…
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Affinity-optimized bispecific CAR-T cells targeting HLA-G and CD70 for the treatment of clear cell renal cell carcinoma" doi.org/10.1136/jitc-2026-01…
Society for Immunotherapy of Cancer retweeted
New #JITC article: "AI-derived 3D body composition predicts prognosis of chemoimmunotherapy in small cell lung cancer: a multicenter study" doi.org/10.1136/jitc-2026-01…
Explore systems immunology and T cell memory with #SITC! Join us Oct. 27 for the next webinar in the Computational IO Series and hear from experts about computational approaches advancing our understanding of immune responses. Register today! sitcancer.org/edu/webinars/c…
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Dietary fat boosts lung tissue-specific antitumor immunity via reprogramming intravascular neutrophils" doi.org/10.1136/jitc-2026-01…
Society for Immunotherapy of Cancer retweeted
👉
Abstract submissions for Spring Scientific are open through Dec. 3, 2026. Don’t miss this opportunity to share your research with your colleagues and fellow immuno-oncology professionals. Learn more about the program and register: sitcancer.org/edu/2027-sprin…
Society for Immunotherapy of Cancer retweeted
We’re presenting our trial in progress at #SITC2026 in Phoenix: BND-22 in combination with cemiplimab in patients with cholangiocarcinoma. @ANaingMD @UTMDAnderson @sitcancer
🤖 Made with AI
Society for Immunotherapy of Cancer retweeted
We’re pleased to share that a Genelux Trial-in-Progress abstract has been accepted for presentation at #SITC26!
The presentation will highlight the clinical trial design and science supporting the VIRO-25 clinical trial evaluating Olvimulogene Nanivacirepvec (Olvi-Vec), an oncolytic vaccinia virus-based immunotherapy, in combination with chemotherapy and an immune checkpoint inhibitor in non-small cell lung cancer.
Abstract #540: Clinical trial of Olvimulogene Nanivacirepvec (Olvi-Vec), an oncolytic vaccinia virus-based immunotherapy, plus chemotherapy and an immune checkpoint inhibitor in Non-Small Cell Lung Cancer (VIRO-25).
We look forward to seeing you in Phoenix, Nov. 4–8!
Learn more about the @sitcancer's 41st Annual Meeting and register: sitcancer.org/2026/home
Discover what’s on the horizon for cancer immunotherapy at the New Agents in Development and Emerging Technologies Workshop. Explore the innovative therapies and technologies poised to shape the next generation of IO. Register for #SITC26! sitcancer.org/2026/register-…
Abstract submissions for Spring Scientific are open through Dec. 3, 2026. Don’t miss this opportunity to share your research with your colleagues and fellow immuno-oncology professionals. Learn more about the program and register: sitcancer.org/edu/2027-sprin…